Marie Payton
Technik-/Wissenschafts-/F&E-Leiter bei LOGICBIO THERAPEUTICS, INC.
Profil
Marie Payton is currently the VP-Clinical Development Operations at LogicBio Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Aileron Therapeutics, Inc. She received an undergraduate degree from the University of Massachusetts and an MBA from F.W.
Olin Graduate School of Business.
Aktive Positionen von Marie Payton
| Unternehmen | Position | Beginn |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 |
Ehemalige bekannte Positionen von Marie Payton
| Unternehmen | Position | Ende |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Geschäftsführer | - |
Ausbildung von Marie Payton
| F.W. Olin Graduate School of Business | Masters Business Admin |
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
